Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties: Endocrinology

Exhalation of I-131 after radioiodine therapy: Dependence on radioactivity applied

Thomas Fischer, Sebastian Weber, Mark Gaidouk, Daniela Kittel, Markus Dietlein, Harald Schicha and Klaus Schomaecker
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 268P;
Thomas Fischer
1Nuclear Medicine, University of Cologne, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastian Weber
1Nuclear Medicine, University of Cologne, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Gaidouk
1Nuclear Medicine, University of Cologne, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniela Kittel
1Nuclear Medicine, University of Cologne, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Dietlein
1Nuclear Medicine, University of Cologne, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harald Schicha
1Nuclear Medicine, University of Cologne, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Klaus Schomaecker
1Nuclear Medicine, University of Cologne, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1215

Objectives: Previous results suggested that in radioiodide-treatment (RIT), radioactive iodide must pass through the thyroid glands in order for it to be exhaled in a predominantly organically bound form. Our aim was to establish, through animal experiments, whether the extend and chemical form of the exhaled I-131 iodine is dependent on the dose of radioactivity applied. Methods: Five different doses of I-131 (0.1, 1, 2, 10 and 23 MBq/animal) were given orally to female mice (strain: Balb/c, weight 25 g), and the exhaled iodine was collected in an air flow sampler. Different forms of iodine (aerosol, elementary, organically bound and other forms) were adsorbed onto various filters over a 5-hour collecting period, according to their chemical forms. Levels of radioactivity in the filters were measured with a well counter, 5 mice being studied for each dose of radioactivity. Results: The absolute amount of exhaled radioactivity in Bq rose exponentially in relation to the dose of activity applied. The proportion of exhaled to applied activity at 1-23 MBq remained constant, at c. 0.3%. On administration of just 0.1 MBq, a markedly higher percentage (0.9%) was exhaled. The lowest fraction of iodine exhaled was that bound to aerosols, at all activities tested, while the highest fraction of the exhaled radioiodine was in an organically bound form. This portion lay between 67 and 78% at all activity doses administered. The ratios of the various forms of exhaled radioiodine to one another showed no significant dependence on activities applied. Conclusions: Increasing the activity applied has no effect on the ratios of the various chemical forms of the exhaled radioiodine to one another, but does produce a predictable increase in the total level of radioactivity exhaled. This conclusion can be drawn not only from the results obtained from the present study on mice but also from values obtained in previous studies on RIT patients. In mice, the ratio of exhaled activity to applied activity was about ten times higher than in patients, which could possibly be attributed to differences in the metabolism of mice and humans.

  • Society of Nuclear Medicine, Inc.
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 48, Issue supplement 2
May 1, 2007
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Exhalation of I-131 after radioiodine therapy: Dependence on radioactivity applied
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Exhalation of I-131 after radioiodine therapy: Dependence on radioactivity applied
Thomas Fischer, Sebastian Weber, Mark Gaidouk, Daniela Kittel, Markus Dietlein, Harald Schicha, Klaus Schomaecker
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 268P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Exhalation of I-131 after radioiodine therapy: Dependence on radioactivity applied
Thomas Fischer, Sebastian Weber, Mark Gaidouk, Daniela Kittel, Markus Dietlein, Harald Schicha, Klaus Schomaecker
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 268P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties: Endocrinology

  • Low dose I-123 MIBG diagnostic scan is inferior to I-131 MIBG post-treatment scan in detection of neuroblastoma
  • A comparison of the psychological status in the patients with hyperthyroidism before and after treatment with radioiodine-131
  • The correlation between salivary gland uptake in pre- and post-ablative 131I whole body scan and late salivary gland side effect after initial radioactive iodine therapy
Show more General Clinical Specialties: Endocrinology

Endocrinology Posters

  • Low dose I-123 MIBG diagnostic scan is inferior to I-131 MIBG post-treatment scan in detection of neuroblastoma
  • The frequency of vomiting after outpatient I-131 therapy (tx) in patients (pts) with well-differentiated thyroid cancer (WDTC)
  • A comparison of the psychological status in the patients with hyperthyroidism before and after treatment with radioiodine-131
Show more Endocrinology Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire